Foamix Pharmaceuticals Ltd (FOMX) related to its sale to Menlo Therapeutics, Inc. Under the terms of the transaction, Foamix shareholders will have the right to receive 0.5924 shares of Menlo common stock and one contingent stock right for each Foamix common stock owned.